ArticleFrontiers in medicine2026
Impact of blood sampling time deviations on vancomycin therapeutic drug monitoring and clinical decision-making.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the impact of deviations in blood sampling time on the interpretation of measured trough concentrations in vancomycin therapeutic drug monitoring; to explore a reference time window for early blood sampling in clinical settings where trough concentration monitoring remains the primary approach. Methods: A retrospective analysis was conducted on 160 therapeutic drug monitoring (TDM) records from inpatients receiving vancomycin TDM in our hospital between March 2024 and March 2026. Among these, 137 early-sampled cases were included for analysis, with predicted trough concentrations (C_pred) obtained using the Pharmado platform. Using C_pred as a model-assisted reference, the relative standard deviation (RSD) of measured concentrations (C_obs) was calculated. The target range of 10-20 μg/mL was applied to assess misjudgments in target attainment. Spearman correlation and Logistic regression analyses were employed to evaluate the relationship between time deviation (Δt) and RSD. Results: C_obs exhibited a systematic tendency toward overestimation compared to C_pred, with a significant positive correlation between Δt and RSD ( Conclusion: Early blood sampling in vancomycin TDM can lead to systematic overestimation of trough concentrations, with greater deviations associated with longer early sampling times. When the blood sampling time is advanced by ≤1 h, the deviation between the measured concentration and the predicted trough concentration is minimal. Under the condition that the sampling time is accurately recorded, the measured value may be cautiously used for target concentration assessment. If the sampling time falls outside this window, either platform-based correction or re-sampling is recommended. The proposed 1-h threshold should be interpreted as an exploratory, model-dependent reference rather than a definitive clinical cutoff.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.